Julia Chapman
Corporate Officer/Principal bij BridgeBio Pharma LLC
Profiel
Julia Chapman is currently working as the Vice President of Business Development & Strategy at BridgeBio Pharma LLC.
Previously, she worked as the Senior Vice President of Corporate Strategy & Planning at Verve Therapeutics, Inc. Ms. Chapman completed her undergraduate degree and earned an MBA from Duke University.
Actieve functies van Julia Chapman
| Bedrijven | Functie | Begin |
|---|---|---|
BridgeBio Pharma LLC
 BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Eerdere bekende functies van Julia Chapman
| Bedrijven | Functie | Einde |
|---|---|---|
| VERVE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Julia Chapman
| Duke University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Health Technology |